Cracking Salmonella Typhis Secret Code: Understanding Pathogenic Mechanisms of Salmonella Typhi Toxin

破解伤寒沙门菌密码:了解伤寒沙门菌毒素的致病机制

基本信息

  • 批准号:
    10404508
  • 负责人:
  • 金额:
    $ 53.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-06-04 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT Typhoid fever, caused by Salmonella enterica serovar Typhi (S. Typhi), is one of the most successful infectious diseases in human history and remains a major global health threat with continuing outbreaks in developing countries. Typhoid fever kills 0.2 million and sickens 21 million people every year. Multidrug-resistant strains of S. Typhi is rapidly spreading. One of the most effective countermeasures alternative to antibiotics would be targeting essential virulence mechanisms of typhoid fever. However, little is known about the pathogenic mechanisms specific to S. Typhi. One such essential virulence factor specific to S. Typhi is a recently discovered toxin: typhoid toxin. Typhoid toxin has many unique structural and functional features. This toxin consists of three subunits, CdtB (nuclease), PltA (mono ADP ribosyltransferase), and a homopentamer of PltB (receptor binding), resulting in its unique A2B5 stoichiometry. When administered to laboratory animals, typhoid toxin recapitulated many of the characteristic symptoms of typhoid fever, such as lethargy, malaise, stupor, leukopenia, and neurological complications. It is expected that typhoid toxin plays a similar role during human infection, as supported by clinical reports indicating the abundant presence of anti-typhoid toxin antibodies in the sera of convalescent typhoid patients, as well as our recent studies demonstrating the expression of the specific glycan receptor for typhoid toxin on cells resulting in typhoid symptoms. However, we still do not have a good understanding of how each subunit of typhoid toxin contributes to its virulence. To fill this gap in our knowledge, here we aim to define the precise role(s) of typhoid toxin’s subunits in virulence, with an emphasis on roles of PltA and PltB. The proposed research is significant because this work will offer important insights into the development of effective strategies for targeting the pathogenic mechanisms specific to S. Typhi and attenuating S. Typhi virulence.
项目总结/摘要 伤寒,由伤寒沙门氏菌引起。伤寒),是最成功的传染病之一, 疾病,仍然是一个主要的全球健康威胁,在发展中国家持续爆发, 国家伤寒每年造成20万人死亡,2100万人患病。多重耐药菌株 S.伤寒正在迅速蔓延。抗生素最有效的替代措施之一是 针对伤寒的基本毒力机制。然而,对致病性 S.伤寒其中一个重要的毒力因子是S.伤寒是最近发现的 伤寒毒素。伤寒毒素具有许多独特的结构和功能特征。这种毒素由三种成分组成 亚基、CdtB(核酸酶)、PltA(单ADP核糖基转移酶)和PltB的同五聚体(受体结合), 导致其独特的A2 B5化学计量。当给实验室动物注射伤寒毒素时, 伤寒的许多特征性症状,如嗜睡、不适、昏迷、白细胞减少, 神经系统并发症预期伤寒毒素在人类感染期间起类似作用, 临床报告表明,在患者血清中存在大量的抗伤寒毒素抗体, 恢复期伤寒患者,以及我们最近的研究表明,表达的特定聚糖 细胞上伤寒毒素的受体导致伤寒症状。然而,我们仍然没有一个好的 了解伤寒毒素的每个亚单位如何影响其毒力。为了填补我们知识上的空白, 在这里,我们的目标是确定伤寒毒素的亚单位在毒力中的确切作用,重点是 PltA和PltB。拟议的研究是重要的,因为这项工作将提供重要的见解 发展针对S.伤寒和减毒型 S.伤寒毒力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeongmin Song其他文献

Jeongmin Song的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeongmin Song', 18)}}的其他基金

Cracking Salmonella Typhis Secret Code: Understanding Pathogenic Mechanisms of Salmonella Typhi Toxin
破解伤寒沙门菌密码:了解伤寒沙门菌毒素的致病机制
  • 批准号:
    10164712
  • 财政年份:
    2018
  • 资助金额:
    $ 53.86万
  • 项目类别:
Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
  • 批准号:
    10425840
  • 财政年份:
    2018
  • 资助金额:
    $ 53.86万
  • 项目类别:
Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
  • 批准号:
    9762253
  • 财政年份:
    2018
  • 资助金额:
    $ 53.86万
  • 项目类别:
Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
  • 批准号:
    10543076
  • 财政年份:
    2018
  • 资助金额:
    $ 53.86万
  • 项目类别:
Salmonella Typhi: Enhancement of Endemic Potential through its Unique Virulence Factors
伤寒沙门氏菌:通过其独特的毒力因子增强地方病的可能性
  • 批准号:
    10308674
  • 财政年份:
    2018
  • 资助金额:
    $ 53.86万
  • 项目类别:
Typhoid Vaccines Targeting Both Salmonella Typhi and Its Secreted Virulence Factor
针对伤寒沙门氏菌及其分泌的毒力因子的伤寒疫苗
  • 批准号:
    10403451
  • 财政年份:
    2018
  • 资助金额:
    $ 53.86万
  • 项目类别:
Typhoid Vaccines Targeting Both Salmonella Typhi and Its Secreted Virulence Factor
针对伤寒沙门氏菌及其分泌的毒力因子的伤寒疫苗
  • 批准号:
    10160775
  • 财政年份:
    2018
  • 资助金额:
    $ 53.86万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 53.86万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了